Lobbying Information
Subject Matters
- Aboriginal Affairs
- Health
- Industry
- Intellectual Property
- Science and Technology
- Taxation and Finance
Subject Matter Details
Legislative Proposal, Bill or Resolution
- C-51 Act to amend the food and drug act and to make consequential amendment to other acts with respect to pharmacovigilance and reporting requirements
Legislative Proposal, Bill or Resolution, Regulation
- Similar Entry Biologics (SEBs): requiring a Health Canada regulatory framework that support the approval of SEBs
Policies or Program
- Common Drug Review (CDR), with respect to health economics assessment and recommendations made on new medicines.
- Federal Government Non Insured Health Benefits program with respect to reimbursement of a prescription medicine and changes in type of reimbursement
Regulation
- Industry Canada Patented Medicines Notice of Compliance (PMNOC) Regulations, as this relates to regulating intellectual property of prescription drugs
- Patented Medicine Prices Review Board (PMPRB) Regulations.
with regard to prices charged by patentees for patented medicines sold in Canada.
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Aboriginal Affairs and Northern Development Canada
-
Canadian Institutes of Health Research (CIHR)
-
Correctional Service of Canada (CSC)
-
Health Canada (HC)
-
House of Commons
-
Immigration and Refugee Board (IRB)
-
Industry Canada
-
National Defence (DND)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Public Works and Government Services Canada
-
Royal Canadian Mounted Police (RCMP)
-
Service Health Care Plan
-
Veterans Affairs Canada (VAC)
In-house Corporation Details
Description of activities
Abbott is a broad-based health care company that discovers, develops, manufacturers and markets products that span the continuum of care - from prevention and diagnosis to treatment and cure. Abbott's principal businesses include medical products, including devices, diagnostic tests and instruments, nutritionals for children and adults, and pharmaceuticals.
Responsible officer name and position during the period of this registration
Jeffrey Devlin,
Director, Government & External Affairs
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
8401 Transcanada Highway
St-Laurent, QC H4S 1Z1
Canada
Telephone number:
514-832-7126
Fax number:
514832 7858
Parent Company Information
- Abbott Laboratories
-
100 Abbott Park Rd
Abbott Park, IL 60064-3500
United States of America
Subsidiary Beneficiary Information
Abbott Laboratories does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Linda Assouline,
Associate Medical Director |
No public offices held
- Loretta Del Bosco,
Director, Regulatory Affairs & Quality Assurance |
No public offices held
- Laurie Dotto,
Director Government & External Affairs |
No public offices held
- Caroline Jacques,
Senior Counsel, Latin America, Canada |
No public offices held
- Dr Tom Koutsavlis,
Medical Director |
No public offices held
- David Link,
National Manager Market Access & Governmental Affairs |
No public offices held
- Judith Mergl,
Senior Manager Regulatory Affairs |
No public offices held
- Diana Parison,
Senior Manager Market Access Planning & HE |
No public offices held
- Andrew Wynn,
Provincial Affairs Manager |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
- Philip Schwab,
Senior Manager, Federal Government Affairs |
No public offices held
